Retraction
Ca2+/calmodulin-dependent protein kinase IIgamma, a critical mediator of the NF-kappaB network, is a novel therapeutic target in non-small cell lung cancer
Paper Information
Record ID:
16666
Author(s):
Journal:
Publication Date:
November 01, 2013
Retraction Date:
December 22, 2017
(7.9 years years ago)
Subjects:
Broad Categories:
Biology
Biology
Institutions:
- Department of Respiratory Medicine, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China
- Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education & Cancer Institute, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China
- Department of Hematology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China
- Department of Pathology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China
- Division of Gene Regulation, Beckman Research Institute, City of Hope National Medical Center, 1500 E. Duarte Road, Duarte, CA 91010, USA
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Elsevier
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1016/j.canlet.2017.11.029Citations (19)
19
Total Citations11
Post-Retraction(57.9%)
7
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
1
Within 1 year
5
After 2+ years
1791
Days since retraction (latest)
Paper citing Ca2+/calmodulin-dependent protein kinase IIgamma, ...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Ca2+/calmodulin-dependent protein kinase IIgamma, ...
Unknown Authors
Unknown Journal
Published: Nov 2022
1791 days after retraction
Discovery of a New CaMKII-Targeted Synthetic Lethal Therapy against Glioblastoma Stem-like Cells
Jang Mi Han, Yu Jin Kim, Hye Jin Jung
Cancers
Open Access
Published: Mar 2022
15 citations
15 citations
1533 days after retraction
The Calcium/Calmodulin-Dependent Kinases II and IV as Therapeutic Targets in Neurodegenerative and Neuropsychiatric Disorders
Kinga Sałaciak, Aleksandra Koszałka, Elżbieta Żmudzka et al. (4 authors)
International Journal of Molecular Sciences
Open Access
Published: Apr 2021
45 citations
45 citations
1216 days after retraction
CaMKII Mediates TGFβ1-Induced Fibroblasts Activation and Its Cross Talk with Colon Cancer Cells
Wei Chen, Yanwei Chen, Juan Su et al. (9 authors)
Digestive Diseases and Sciences
Published: Feb 2021
10 citations
10 citations
1138 days after retraction
Ketamine inhibits aerobic glycolysis in colorectal cancer cells by blocking the NMDA receptor‐CaMK II‐c‐Myc pathway
Jianjun Hu, Wenming Duan, Yahua Liu
Clinical and Experimental Pharmacology and Physiology
Published: Dec 2019
22 citations
22 citations
739 days after retraction
Paper citing Ca2+/calmodulin-dependent protein kinase IIgamma, ...
Unknown Authors
Unknown Journal
Published: Oct 2019
672 days after retraction
Oxidative CaMKII as a potential target for inflammatory disease (Review)
Jingjing Qu, Quanhui Mei, Ruichao Niu
Molecular Medicine Reports
Open Access
Published: May 2019
12 citations
12 citations
523 days after retraction
Paper citing Ca2+/calmodulin-dependent protein kinase IIgamma, ...
Unknown Authors
Unknown Journal
Published: Apr 2019
465 days after retraction
Ketamine inhibits colorectal cancer cells malignant potential via blockage of NMDA receptor
Wenming Duan, Jianjun Hu, Yahua Liu
Experimental and Molecular Pathology
Published: Feb 2019
43 citations
43 citations
430 days after retraction
Inhibition of CaMKIIα Activity Enhances Antitumor Effect of Fullerene C60 Nanocrystals by Suppression of Autophagic Degradation
Jing Xu, Hongsheng Wang, Yi Hu et al. (18 authors)
Advanced Science
Open Access
Published: Feb 2019
50 citations
50 citations
415 days after retraction
Paper citing Ca2+/calmodulin-dependent protein kinase IIgamma, ...
Unknown Authors
Unknown Journal
Published: Dec 2018
348 days after retraction
Ca<sup>2+</sup>/calmodulin-dependent protein kinase II regulates colon cancer proliferation and migration <i>via</i> ERK1/2 and p38 pathways
Wei Chen, Ping An, Xiaojing Quan et al. (7 authors)
World Journal of Gastroenterology
Open Access
Published: Sep 2017
41 citations
41 citations
106 days before retraction
Propofol attenuates pancreatic cancer malignant potential via inhibition of NMDA receptor
Xiangyuan Chen, Qichao Wu, You Li et al. (6 authors)
European Journal of Pharmacology
Published: Dec 2016
59 citations
59 citations
374 days before retraction
Paper citing Ca2+/calmodulin-dependent protein kinase IIgamma, ...
Unknown Authors
Unknown Journal
Published: May 2016
582 days before retraction
Paper citing Ca2+/calmodulin-dependent protein kinase IIgamma, ...
Unknown Authors
Unknown Journal
Published: Mar 2016
661 days before retraction
Paper citing Ca2+/calmodulin-dependent protein kinase IIgamma, ...
Unknown Authors
Unknown Journal
Published: Feb 2016
686 days before retraction
The emerging role of CaMKII in cancer
Yanyang Wang, Ren Zhao, Hong Zhe
Oncotarget
Open Access
Published: Apr 2015
102 citations
102 citations
968 days before retraction
Paper citing Ca2+/calmodulin-dependent protein kinase IIgamma, ...
Unknown Authors
Unknown Journal
Published: Apr 2015
978 days before retraction
Related Records
This article has multiple records in the database due to different notices:
Record #16667
Aug 01, 2016Quick Stats
Total Citations:
19
Years Since Retraction:
7.9 years
Open Access:
Yes
Last Checked:
Never